A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524)

International Journal of Radiation Oncology, Biology, Physics, Volume 97, Issue 5, 2017 Apr 1 | Michaelson, M. Dror, MD, PhD; Hu, Chen, PhD; Pham, Huong T., MD;...
Summary Standard treatment for muscle-invasive urothelial cancer of the bladder is radical cystectomy. Bladder preservation with a combination of radiation and chemotherapy is a well-established alternative to surgery. In this study we treated pat...

http://ift.tt/2nj3AZp